The development marks an important step in Sigachi's strategic focus on expanding its presence in complex, high-value specialty APIs, aligned with global demand for advanced therapies in rare and chronic disease segments
The platform aims to serve doctors, consumers, and healthcare facilities by providing AI-assisted clinical decision tools, personalized health insights, and improved diagnostic capabilities
USFDA determines Sun Pharma's Baska facility inspection classification as OAI
The non-dilutive financing includes three tranches
The formulation is backed by over 80 clinical trials and 200 scientific publications
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
Subscribe To Our Newsletter & Stay Updated
